|
EDEM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.172770E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.572200E-02 |
| Normal-vs-Stage2 |
7.751800E-01 |
| Normal-vs-Stage3 |
7.226600E-01 |
| Normal-vs-Stage4 |
5.392600E-01 |
| Stage1-vs-Stage2 |
1.359560E-01 |
| Stage1-vs-Stage3 |
3.709400E-01 |
| Stage1-vs-Stage4 |
9.476200E-01 |
| Stage2-vs-Stage3 |
6.341000E-01 |
| Stage2-vs-Stage4 |
4.303200E-01 |
| Stage3-vs-Stage4 |
6.424600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.295700E-02 |
| Normal-vs-AfricanAmerican |
3.274200E-01 |
| Normal-vs-Asian |
3.317900E-02 |
| Caucasian-vs-AfricanAmerican |
6.163000E-01 |
| Caucasian-vs-Asian |
5.066400E-01 |
| AfricanAmerican-vs-Asian |
3.843600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.415100E-04 |
| Normal-vs-Female |
6.126300E-02 |
| Male-vs-Female |
1.047460E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.924400E-01 |
| Normal-vs-Extreme_Weight |
1.084410E-03 |
| Normal-vs-Obese |
7.750000E-01 |
| Normal-vs-Extreme_Obese |
4.976100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.440600E-01 |
| Normal_Weight-vs-Obese |
4.932800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.269200E-01 |
| Extreme_Weight-vs-Obese |
2.882400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.043000E-01 |
| Obese-vs-Extreme_Obese |
1.654190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.966800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.730800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.283800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.220430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.731440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.713600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.130980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.302190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.806600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.097200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.996500E-03 |
| Normal-VS-Type2 PRCC |
2.274300E-02 |
| Normal-VS-KIRP CIMP |
2.661600E-02 |
| Normal-VS-Unclassified PRCC |
8.012200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.199000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.055580E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.888240E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.172420E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.579800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.342000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.879090E-03 |
| Normal-vs-N1 |
7.048800E-01 |
| Normal-vs-N2 |
6.790600E-01 |
| N0-vs-N1 |
2.585600E-01 |
| N0-vs-N2 |
4.822600E-01 |
| N1-vs-N2 |
6.322600E-01 |
|
|
